PRELUDE CAPITAL MANAGEMENT, LLC - ATHIRA PHARMA INC ownership

ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 78 filers reported holding ATHIRA PHARMA INC in Q2 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of ATHIRA PHARMA INC
ValueSharesWeighting
Q3 2023$64,482
-23.9%
31,922
+11.1%
0.00%
-33.3%
Q2 2023$84,730
-21.1%
28,722
-33.1%
0.01%0.0%
Q1 2023$107,393
-46.0%
42,957
-31.5%
0.01%
-40.0%
Q4 2022$198,829
+9.2%
62,722
+2.5%
0.01%
+42.9%
Q3 2022$182,000
+87.6%
61,222
+92.5%
0.01%
+133.3%
Q2 2022$97,000
-34.9%
31,800
+189.1%
0.00%
-25.0%
Q1 2022$149,000
+52.0%
11,000
+5.8%
0.00%
+33.3%
Q3 2021$98,00010,4000.00%
Other shareholders
ATHIRA PHARMA INC shareholders Q2 2023
NameSharesValueWeighting ↓
VR Adviser, LLC 1,691,623$31,126,0003.38%
ACUTA CAPITAL PARTNERS, LLC 400,000$7,360,0002.65%
Logos Global Management LP 1,010,812$18,599,0001.82%
S Squared Technology, LLC 181,220$3,334,0001.58%
Avidity Partners Management LP 1,677,845$30,872,0000.85%
Perceptive Advisors 3,425,916$63,037,0000.80%
RTW INVESTMENTS, LP 2,652,553$48,807,0000.76%
Sofinnova Investments, Inc. 509,168$9,369,0000.56%
HighVista Strategies LLC 32,062$590,0000.44%
DAFNA Capital Management LLC 91,531$1,684,0000.40%
View complete list of ATHIRA PHARMA INC shareholders